NAMI Advocacy Actions

Letter to Congressional bill sponsors in support of H.R. 3173/S. 3018, The Improving Seniors Timely Access to Care Act, which would improve the prior authorization process in Medicare Advantage.

Letter to Senate Finance Committee Chairman Wyden and Ranking Member Crapo, urging the Committee to include the Non-Opioids Prevent Addiction in the Nation (“NOPAIN”) Act (S. 586) in the mental health legislative package currently under development.

Letter to Appropriations Committee leadership, requesting $3.75 billion for the Centers for Disease Control and Prevention’s National Center for Chronic Disease Prevention and Health Promotion.

Letter to Senators Kaine and Young and Representatives Wild and McKinley, in thanks for championing H.R. 1667, the Dr. Lorna Breen Health Care Provider Protection Act, and ensuring its passage.

Statement on consensus health care reform principles, including affordability, accessibility, adequacy and comprehensiveness.

Letter to Senators Kaine and Young and Representatives Wild and McKinley, in thanks for championing H.R. 1667, the Dr. Lorna Breen Health Care Provider Protection Act, and ensuring its passage.

Letter to Administrator Brooks-LaSure, requesting that CMS take action to address a the lack of timely operating room access for individuals with disabilities in need of dental surgical services.

Letter to Healthy Future Task Force leadership, providing feedback on the Task Force's Request For Information on health care affordability.

Letter to Speaker Pelosi and Leader Schumer, urging continued support for civil monetary penalty authority for the U.S. Department of Labor to enforce the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 (MHPAEA).

Letter to the FDA regarding reporting and treatment recommendation updates to the Clozapine Risk Evaluation and Mitigation Strategies (REMS) surveillance system.